150 related articles for article (PubMed ID: 1308788)
21. [Sorbitol route of glucose metabolism and complication of diabetes mellitus].
Efimov AS; Skrobonskaia NA; Petakh NN
Probl Endokrinol (Mosk); 1980; 26(3):86-90. PubMed ID: 6773043
[No Abstract] [Full Text] [Related]
22. Levels of expression of hexokinase, aldose reductase and sorbitol dehydrogenase genes in lens of mouse and rat.
Wen Y; Bekhor I
Curr Eye Res; 1993 Apr; 12(4):323-32. PubMed ID: 8319491
[TBL] [Abstract][Full Text] [Related]
23. Sugar alcohols in the pathogenesis of galactose and diabetic cataracts.
van Heyningen R
Birth Defects Orig Artic Ser; 1976; 12(3):295-303. PubMed ID: 821562
[No Abstract] [Full Text] [Related]
24. Sugar metabolism in the crystalline lens.
Chylack LT; Cheng HM
Surv Ophthalmol; 1978; 23(1):26-37. PubMed ID: 100892
[TBL] [Abstract][Full Text] [Related]
25. Etiology of cataracts in diabetics.
Varma SD; Richards RD
Int Ophthalmol Clin; 1984; 24(4):93-110. PubMed ID: 6438012
[No Abstract] [Full Text] [Related]
26. Long-term effect of Trigonella foenum graecum and its combination with sodium orthovanadate in preventing histopathological and biochemical abnormalities in diabetic rat ocular tissues.
Preet A; Siddiqui MR; Taha A; Badhai J; Hussain ME; Yadava PK; Baquer NZ
Mol Cell Biochem; 2006 Sep; 289(1-2):137-47. PubMed ID: 16718375
[TBL] [Abstract][Full Text] [Related]
27. GP-1447, an inhibitor of aldose reductase, prevents the progression of diabetic cataract in rats.
Kawakubo K; Mori A; Sakamoto K; Nakahara T; Ishii K
Biol Pharm Bull; 2012; 35(6):866-72. PubMed ID: 22687477
[TBL] [Abstract][Full Text] [Related]
28. Comparison of glucose, sorbitol and fructose accumulation in lens and liver of diabetic and insulin-treated rats and mice.
Gaynes BI; Watkins JB
Comp Biochem Physiol B; 1989; 92(4):685-90. PubMed ID: 2498032
[TBL] [Abstract][Full Text] [Related]
29. NADPH-oxidising activity in lens and erythrocytes in diabetic and nondiabetic patients with cataract.
Crabbe MJ; Bron AJ; Peckar CO; Petchey M; Ting HH; Howard-Williams J
Br J Ophthalmol; 1983 Oct; 67(10):696-9. PubMed ID: 6412739
[TBL] [Abstract][Full Text] [Related]
30. Control of sorbitol metabolism in renal inner medulla of diabetic rats: regulation by substrate, cosubstrate and products of the aldose reductase reaction.
Grunewald RW; Weber II; Kinne-Saffran E; Kinne RK
Biochim Biophys Acta; 1993 Nov; 1225(1):39-47. PubMed ID: 8241288
[TBL] [Abstract][Full Text] [Related]
31. Diabetic cataracts in animal models: prevention and reversibility with aldose reductase inhibitors.
Kador PF; Akagi Y; Kinoshita JH
Diabet Med; 1985 May; 2(3):194-6. PubMed ID: 2952419
[No Abstract] [Full Text] [Related]
32. Lens aldose reductase in diabetic and galactosemic cataracts.
Parmar NS; Ghosh MN
Indian J Physiol Pharmacol; 1981; 25(3):193-200. PubMed ID: 6795119
[No Abstract] [Full Text] [Related]
33. [Effects of vanadate on glucose metabolism of the streptozotocin-diabetic rat lens].
Endo M
Nippon Ganka Gakkai Zasshi; 1993 Mar; 97(3):333-9. PubMed ID: 8317350
[TBL] [Abstract][Full Text] [Related]
34. Activities of NADPH-dependent reductases and sorbitol dehydrogenase in canine and feline lenses.
Salgado D; Forrer RS; Spiess BM
Am J Vet Res; 2000 Oct; 61(10):1322-4. PubMed ID: 11039569
[TBL] [Abstract][Full Text] [Related]
35. NADPH-dependent reduction of glyceraldehyde: a unusually high activity in the lens of the camel (Camelus dromedarius).
Del Corso A; Osman AM; Mohamed AS; Camici M; Barsacchi D; Tozzi MG; Mura U
Boll Soc Ital Biol Sper; 1989 Mar; 65(3):235-42. PubMed ID: 2504255
[TBL] [Abstract][Full Text] [Related]
36. Efficacy of Alrestatin, an aldose reductase inhibitor, in human diabetic and nondiabetic lenses.
Chylack LT; Henriques HF; Cheng HM; Tung WH
Ophthalmology; 1979 Sep; 86(9):1579-85. PubMed ID: 121768
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of polyol pathway activity in diabetic and galactosemic rats by the aldose reductase inhibitor CP-45,634.
Peterson MJ; Sarges R; Aldinger CE; MacDonald DP
Adv Exp Med Biol; 1979; 119():347-56. PubMed ID: 115231
[No Abstract] [Full Text] [Related]
38. Diabetic cataracts- is aldose reductase important?
Crabbe MJ; Wolff S; Halder AB; Ting HH
Metab Pediatr Ophthalmol; 1981; 5(1):33-8. PubMed ID: 6789018
[No Abstract] [Full Text] [Related]
39. The effects of a new aldose reductase inhibitor (tolrestat) in galactosemic and diabetic rats.
Simard-Duquesne N; Greselin E; Dubuc J; Dvornik D
Metabolism; 1985 Oct; 34(10):885-92. PubMed ID: 3930915
[TBL] [Abstract][Full Text] [Related]
40. [Sorbitol pathway of glucose metabolism in streptozotocin diabetes of varying duration and severity].
Efimov AS; Obrosova IG; Velikiĭ NN
Probl Endokrinol (Mosk); 1984; 30(2):71-6. PubMed ID: 6425821
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
